Cadila Healthcare

Buy on Cadila Healthcare with target of Rs 370

We initiate coverage on Cadila Healthcare (CDH) with BUY and a Mar17 TP of `370.

Cadila gets US FDA nod to sell generic anti-viral drug

The drugs will be manufactured in Ahmedabad

Zydus acquires gastro therapy ‘Actibile’ from Albert David

Strengthens its presence in the gastroenterology segment Zydus Healthcare, a wholly-owned subsidiary of Cadila Healthcare has entered into a definitive agreement to acquire ‘Actibile’ from Albert David. The brand

9 stocks that remained in news today: Lupin, Excel Industries and more

Zydus Healthcare, a subsidiary of Cadila Healthcare, has acquired gastrointestinal brand 'Actibile' from drug firm Albert David for an undisclosed amount.

9 stocks that remained in news today: Lupin, Excel Industries and more

Cadila Q3 net up 38 per cent at Rs 390 cr

Total income of the company rose to Rs 2,428 crore for the third quarter

FIPB clears 5 FDI proposals worth Rs 6,050 cr; Cadila Healthcare gets nod

Government today approved five foreign investment proposals involving an inflow of Rs 6,050 crore including a Rs 5,000-crore plan of Cadila Healthcare for fresh equity infusion.

FIPB clears 5 FDI proposals worth Rs 6,050 cr; Cadila Healthcare gets nod

USFDA alleges Cadila’s 2 plants for violating CGMP regulations

Torn notebook with record of 'deficiencies', plastic bags filled with shreds of paperwork, failure to adequately investigate and address consumer complaints, are some of the major norm violations found by the USFDA at Cadila

USFDA alleges Cadila’s 2 plants for violating CGMP regulations

Cadila Healthcare receives warning letter from US FDA

The letters were received for its two facilities in Gujarat Cadila Healthcare has received a warning letter from the US Food and Drug Administration (US FDA) for its two facilities in Gujarat. “The company has received

Top 8 stocks that made news today: Cadila Healthcare, Petronet LNG and more

Gas importer Petronet LNG will buy liquefied natural gas (LNG) from Qatar's Rasgas at virtually half the original cost, the government said in a statement on Thursday.

Top 8 stocks that made news today: Cadila Healthcare, Petronet LNG and more

Cadila Healthcare Ltd shares surge nearly 3% as Q2 net profit zooms 40%

Cadila Healthcare Ltd shares surged on Friday after the company posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16.

Cadila Healthcare Ltd shares surge nearly 3% as Q2 net profit zooms 40%

Cadila Healthcare posts 40% jump in net profit to Rs 391 cr

Pharma firm Cadila Healthcare Ltd posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16.

Cadila beats estimates, US market the key: Nomura

Cadila Healthcare’s (CDH) Q4 results were above our expectations. Revenue recorded a 16% growth...

Focus on innovation: New drugs top Cadila Healthcare’s prescription for growth

In the pipeline are three novel biologics, 10 vaccines, and two new chemical entities set to complete phase 1 clinical trials by end of 2015.

Biosimilars should contribute 10% to our revenue in 5 years

Cadila's new chemical entity (NCE) pipeline includes two new drugs being developed to treat diabetes and anaemia.

Cadila buys JV partner’s 50 per cent stake in Zydus BSV Pharma

Zydus BSV has now become 100 per cent subsidiary of Cadila Healthcare

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement

TRENDING NOW

BUDGET 2019

Related Articles